AbbVie Inc. — Director's Dealing 2017

Sep 12, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2017-09-11

Reporting Person: SALEKI-GERHARDT AZITA (SVP, Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-09-11	Common stock, $0.01 par value	M	4800	$24.2082	Acquired	93099	Direct
2017-09-11	Common stock, $0.01 par value	S	1200	$84.99	Disposed	91899	Direct
2017-09-11	Common stock, $0.01 par value	S	3600	$84.995	Disposed	88299	Direct
2017-09-11	Common stock, $0.01 par value	S	132	$85.03	Disposed	88167	Direct
2017-09-11	Common stock, $0.01 par value	S	1030	$85.04	Disposed	87137	Direct
2017-09-11	Common stock, $0.01 par value	S	2338	$85.06	Disposed	84799	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-09-11	Option (right to buy)	$24.2082	M	4800	Disposed	2021-02-17	Common stock (4800)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, $0.01 par value	1918	Indirect
Common stock, $0.01 par value	3873	Indirect

Footnotes

F1: Balance in the AbbVie Savings Program as of September 11, 2017.

F2: The reporting person disclaims beneficial ownership of all securities held by her spouse.